Agicef T 250mg/31.25mg Injection
Marketer
Aegle Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Agicef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), marketed as Agicef T, combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare provider, this combination drug requires adherence to the prescribed dosage schedule. Complete the full course of treatment, even with symptom improvement, to prevent treatment failure. Discontinuing prematurely can reduce effectiveness. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Report worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions such as rashes, itching, swelling, or breathing difficulties. Inform your doctor of all current medications, particularly if pregnant or breastfeeding, before initiating treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Rest, proper nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the medicine's effects.
Uses of Agicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Agicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Agicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Agicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Agicef T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (Agicef T 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counters bacterial resistance, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from ingesting alcohol while receiving Agicef T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Agicef T 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Agicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Agicef T 250mg/31.25mg Injection could lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Agicef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Agicef T 250mg/31.25mg requires careful administration for individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Agicef T 250mg/31.25mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Agicef T 250mg/31.25mg Injection :
Omitting a scheduled dose of Agicef T 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Agicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently